Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03106025 · ClinicalTrials.gov registry record · NA
Use of Ocular Point of Care Ultrasound in Diagnosing Retinal Detachment in the Emergency Department
A NA study of Retinal Detachment, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03106025: Completed NA study of Retinal Detachment, sponsored by Loma Linda University.
NCT03106025 is a NA study of Retinal Detachment that has completed, run by Loma Linda University. The registered enrollment target is 5 participants, below the 1,092-participant average among 3 other Retinal Detachment trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03106025, a NA study of Retinal Detachment, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is collecting data along with other academic institutions regarding the accuracy of ocular ultrasound in diagnosing retinal detachment.
Primary Outcome
Number of Participants with retinal detachment per ocular ultrasound results
Conditions Studied
Interventions
- DEVICE Ultrasound
- OTHER Ophthalmology Assessment
Study Locations (1)
California
- Loma Linda University Health - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2018-03-25 |
| Phase | NA |
What the finished NCT03106025 record still lists
NCT03106025 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,092-participant average among 3 other Retinal Detachment trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Retinal Detachment appearing as the primary indexed condition, and to 2 interventions - of which Ultrasound is the first listed.
NCT03106025 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03106025 about?
NCT03106025 is a clinical study titled "Use of Ocular Point of Care Ultrasound in Diagnosing Retinal Detachment in the Emergency Department". The study is collecting data along with other academic institutions regarding the accuracy of ocular ultrasound in diagnosing retinal detachment.
What is the current status of trial NCT03106025?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-02-05. Estimated completion is 2018-03-25.
What conditions does trial NCT03106025 study?
This clinical trial studies the following conditions: Retinal Detachment.
What interventions are being tested in trial NCT03106025?
The interventions under investigation include: Ultrasound (DEVICE), Ophthalmology Assessment (OTHER).
Who is sponsoring clinical trial NCT03106025?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03106025 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Detachment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI